FemTech That Scales: Innovation, Evidence, and Adoption

Join a high-impact virtual panel where three Femtech CEO's will unpack what it takes to build and scale a Femtech startup.

Women’s health represents one of the largest and most underdeveloped markets in healthcare — yet building scalable FemTech companies requires more than breakthrough ideas. It demands rigorous evidence, thoughtful regulatory strategy, and real commercial traction.

Join us for a high-impact virtual conversation with leaders who are doing exactly that:

• Selena Shirkin, CEO of Fetal Therapy Technologies
• Saundra Pelletier, CEO of Evofem Biosciences
• Somer Baburek, CEO of Hera Biotech
• Moderator: Fehmida Kapadia, CEO Amplify MedTech

We will discuss

• Translating innovation into clinical adoption
• Building defensible evidence in women’s health
• Navigating regulatory and reimbursement realities
• Scaling in a capital environment that still underestimates the category

Designed for founders, investors, clinicians, and ecosystem leaders, this session will go beyond inspiration and focus on what it truly takes to build FemTech companies that endure.

Meet the Panelists

Saundra Pelletier is the Chief Executive Officer, President and Executive Director of Evofem Biosciences, Inc. (OTCPK: EVFM). During her 10-year tenure at Evofem, she has led the company through its transition to the public market and four consecutive years of net sales growth; the approval of PHEXXI, and the acquisition of SOLOSEC, .Prior to Evofem, she spent more than three decades in the pharmaceutical industry, and has launched pharmaceutical brands worldwide. She is a published author, TEDx and keynote speaker, executive coach and staunch advocate for innovation in women’s healthcare.

Somer Baburek serves as the President & CEO of Hera Biotech, a women’s health company focused on commercializing AI-powered diagnostic tests and devices that improve access, accuracy, and standard of care. Prior to founding Hera, Somer, spent ten years in life science venture capital at Targeted Technology Fund. She also served as the Director of Clinical Operations for Santalis Pharmaceuticals where she expanded its clinical program from a single IND to four active INDs; and from 2 domestic clinical trials to over 10 clinical trials. Somer earned her MBA with a specialization in Data Analytics, from Louisiana State University and graduated Magna Cum Laude from the University of Texas San Antonio with a degree in entrepreneurship.

Selena Shirkin is the Founder and CEO of Fetal Therapy Technologies, the first female-led pediatric microsurgical device companydeveloping purpose-built instruments optimized for the uterine environment to improve the safety of life-saving fetal surgeries. Selena is focused on advancing maternal-fetal medicine and redefining how surgical tools are designed for women’s health. Selena is a Baltimore native and biomedical engineer who graduated from Johns Hopkins University with both her bachelor’s and master’s degrees in Biomedical Engineering.

Moderator

Dr. Fehmida Kapadia is an expert in entrepreneurship, business strategy, and technology commercialization. As the Founder and President of Kapamed Consulting and Amplify MedTech, she has guided over 150 startups in their journey to success.

Dr. Kapadia is also the Managing Director of Fay Ventures, a VC firm that invests in seed-stage MedTech startups.

With a PhD in Biochemistry and a master’s in Biotechnology Entrepreneurship, Dr. Kapadia specializes in strategic partnerships, fundraising, and MedTech commercialization strategy.